Anti-GFP Antibody Market
Anti-GFP Antibody Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Anti-GFP Antibody Market Size and Growth
The Anti-GFP Antibody market is experiencing robust growth, driven by increasing research in gene editing and protein studies. The global market size is projected to reach approximately $150 million by 2026, reflecting a compound annual growth rate of around 8%. Ongoing innovations and rising demand from diverse sectors are key market drivers.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ "FUJIFILM Wako Chemicals"
◍ "ProSci"
◍ "GeneTex"
◍ "Bioss"
◍ "Rockland Immunochemicals"
◍ "Cell Signaling Technology"
◍ "Novus Biologicals"
◍ "Thermo Fisher Scientific"
◍ "Biorbyt"
◍ "R&D Systems"
◍ "BioLegend"
◍ "OriGene Technologies"
◍ "ImmuQuest"
◍ "Abbexa"
◍ "EpiGentek"
◍ "Synaptic Systems"
◍ "Santa Cruz Biotechnology"
◍ "Proteintech Group"
The Anti-GFP Antibody market features key players like Thermo Fisher Scientific and Cell Signaling Technology. These companies drive market growth through product innovation, extensive research, and partnerships, enhancing lab capabilities. Sales revenue for notable firms includes:
- Thermo Fisher Scientific: ~ $30 billion
- BioLegend: ~ $300 million
- Novus Biologicals: ~ $50 million
Request Sample Report
Market Segmentation
By Application
◍ "Biotechnology"
◍ "Medical"
◍ "University"
◍ "Others"
By Product
◍ "Monoclonal Antibody"
◍ "Polyclonal Antibody"
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
